Big Tree Cloud Receives Nasdaq Compliance Notices

Written by Emily J. Thompson, Senior Investment Analyst

Updated: Jan 05 2026

0mins

Should l Buy DSY?

Big Tree Cloud announced that it recently received two notification letters from Nasdaq. The Company received a notification letter from Nasdaq, based on Nasdaq's review of the company's Market Value of Listed Securities, or MVLS, for at least 30 consecutive business days from November 13, 2025 to December 26, 2025, the company's MVLS was below the required minimum of $50M. Pursuant to Nasdaq Listing Rule 5810, the company has been granted a 180-calendar-day compliance period, or until June 29, to regain compliance with the MVLS requirement. To regain compliance, the company's MVLS must close at $50M or more for a minimum of ten consecutive business days during the compliance period. The letter notifies the company of a deficiency but does not immediately affect its Nasdaq listing status. The company also received an additional notification letter from Nasdaq, based on Nasdaq's review of the company's Market Value of Publicly Held Shares, or MVPHS, for at least 30 consecutive business days from November 6, 2025 to December 30, 2025, the company's MVPHS was below the required minimum of $15M. Pursuant to Nasdaq Listing Rule 5810, the company has been granted a 180-calendar-day compliance period, or until June 29, 2026, to regain compliance with the MVPHS requirement. To regain compliance, the company's MVPHS must close at $15M or more for a minimum of ten consecutive business days during the compliance period. The letter notifies the company of a deficiency but does not immediately affect its Nasdaq listing status.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy DSY?" and start using high-conviction signals backed by rigorous historical data.

DSY

$0.242+Infinity%1D

Analyst Views on DSY

About DSY

Big Tree Cloud Holdings Ltd is a holding company mainly engaged in the development, production, distribution and sales of personal care products and other consumer goods. The Company focuses on the production and sales of feminine hygiene products, including sterilized feminine pads and menstrual pants, and its product portfolio consists of Gold Series, DSY Air Series, Aurora Series, Classic Series, Favorita Series, O2 Series, Cloud Pants, and others.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Dassault Systèmes Announces 3DEXPERIENCE World Event

Jan 29 2026Businesswire

Event Timing and Location: Dassault Systèmes will host the 3DEXPERIENCE World event in Houston from February 1-4, attracting thousands of SOLIDWORKS and 3DEXPERIENCE platform users to explore the future of design and manufacturing.
Strong Guest Lineup: The event will feature prominent speakers including Jensen Huang, CEO of NVIDIA, renowned hacker and inventor Pablos Holman, and STEAM advocate Jay Vogler, discussing cutting-edge topics in virtual environment technologies.
AI Technology Showcase: Dassault Systèmes will present a holistic view of its AI technologies, including assistive, predictive, and generative AI, which play a crucial role in enhancing efficiency and sustainability in design, simulation, manufacturing, and governance.
User Base and Innovation Commitment: The AI-powered portfolio aims to deliver value to 8 million users, showcasing Dassault Systèmes' legacy of innovation in advancing product development and emphasizing the significance of AI in transforming work processes.

Dassault Systèmes Half-Year Liquidity Contract Report: €5.38M in Cash

Jan 12 2026Globenewswire

Liquidity Contract Resources: As of December 31, 2025, Dassault Systèmes holds 925,197 shares and €5.38 million in cash under its liquidity contract with Oddo BHF SCA, indicating robust liquidity management that enhances market confidence.
Contract History Overview: Since the liquidity contract's implementation in January 2015, initial cash of €10 million has been increased to €20 million through multiple contributions, reflecting the company's ongoing commitment to liquidity support, which helps stabilize stock price fluctuations.
Trading Activity Analysis: In the second half of 2025, Dassault Systèmes executed 20,126 purchases and 22,371 sales, with a trading volume of 4.86 million shares, indicating high market activity that may attract more investor interest.
Cash Flow Situation: During the same period, total purchases amounted to €128.7 million, while total sales reached €128.1 million, demonstrating effective liquidity management that further enhances its competitiveness in the capital markets.

Cyclerion Therapeutics Expands Collaboration with Medsteer, Shares Surge 44.2%

Jan 06 2026Benzinga

Significant Stock Surge: Cyclerion Therapeutics shares rose 44.2% to $1.99 in pre-market trading, reflecting strong market confidence in the company's expanded strategic collaboration with Medsteer, indicating positive investor sentiment towards future growth prospects.
Deepening Strategic Collaboration: The partnership with Medsteer aims to advance the closed-loop anesthetic platform CYC-126, which is expected to accelerate the product's market entry, thereby enhancing the company's competitive edge in the anesthesia sector.
Optimistic Market Outlook: With continuous advancements in anesthetic technology, Cyclerion's new platform is poised to meet the increasing medical demand, further driving revenue growth and strengthening its position in the healthcare industry.
Increased Investor Confidence: The substantial stock price increase not only reflects market approval of the company's strategic direction but may also attract more investor interest, thereby supporting future financing and expansion efforts.